Centers & Services

The Adult Congenital Heart Disease Center

Patients with congenital heart disease who have some abnormality of the heart from birth might have additional problems as they grow, which differ from those encountered in their childhood. The first full-scale "Adult Congenital Heart Disease Center" in Japan was established on August 1, 2014 because they also need long-term continuing treatment into adulthood.
The Center comprises not only clinical departments to treat the heart including the Department of Cardiovascular Medicine, the Cardiovascular Surgery Department, and the Division of Pediatric Cardiology, but also those of many fields such as Gastroenterology and Hepatology, Nephrology, Obstetrics and Gynecology. We aim to be a representative institution for the treatment and education of adult congenital heart disease in Japan by virtue of our advantageous status as a university hospital.

Management System

Director: Hiroshi Ito
(Professor, Department of Cardiovascular Medicine)
Assistant Director: Teiji Akagi
(Associate Professor, Cardiovascular Intensive Care Unit)

Member departments

Management Policy

Advancements in medicine have enabled patients with congenital heart disease, which had previously been difficult to treat, to grow into adulthood. Now more than 400,000 patients with congenital heart disease have grown up (adult congenital heart disease) in Japan. Their number is estimated to increase at a rate of 10,000 patients per year in the future. Patients with congenital heart disease have been treated by pediatricians to date, simply because no system has been established to transfer them to clinical departments for adults when they reach adulthood.
For adult congenital heart disease, it is necessary to treat not only heart problems but also problems of other organs throughout the body such as the liver and the kidney, in addition to multi-field problems such as pregnancy and delivery in the case of female patients. This Center serves as the window for the problems. The Center can provide consultation in cooperation with many clinical departments using the functions of a university hospital. The Center attempts the smooth transfer of treatment from childhood. Simultaneously, it provides medical care such as reevaluation of patients who have discontinued treatment, consideration for repeat surgery, and treatment for newly discovered heart disease as at the center in the western Japan region in collaboration with regional central medical institutions.
The first visits of outpatients are received on Thursdays (Tuesdays and Thursdays at Cardiovascular Surgery Department) at related clinical departments depending on the patient condition.

Description of major treatment

  • Treatment of heart problems observed in adult congenital heart disease patients
    Heart failure, arrhythmia, pulmonary hypertension, need for repeat surgery, etc.
  • Treatment of problems other than those of the heart observed in adult congenital heart disease patients
    Pregnancy and delivery, liver or kidney complications, periodontal disease, cranial nerve disease, psychiatric disease, etc.
  • Treatment of newly found congenital heart disease
    Catheterization for atrial septal defect and patent ductus arteriosus (largest number of cases in Japan)
  • New catheterization for cerebral infarction and migraine that are regarded as resulting from the heart
    Closure of patent foramen ovale by catheterization in patients with migraine associated with patent foramen ovale